Entry into a New Class of Potent Proteasome Inhibitors Having High Antiproliferative Activity by Structure-Based Design-Reference-Cited by-同舟云学术

Entry into a New Class of Potent Proteasome Inhibitors Having High Antiproliferative Activity by Structure-Based Design

Published:2004-08-19 Issue:20 Volume:47 Page:4810-4813
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Furet Pascal¹,Imbach Patricia¹,Noorani Maria¹,Koeppler Juergen¹,Laumen Kurt¹,Lang Marc¹,Guagnano Vito¹,Fuerst Peter¹,Roesel Johannes¹,Zimmermann Johann¹,García-Echeverría Carlos¹

Affiliation:

1. Novartis Pharma AG, Novartis Institutes for Biomedical Research, CH-4002 Basel, Switzerland

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm049660v

Reference28 articles.

1. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation

2. THE UBIQUITIN SYSTEM

3. The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB

4. Cell cycle regulation by the ubiquitin pathway

5. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Le protéasome, la seconde vie d’une cible thérapeutique validée : aspects structuraux et nouveaux inhibiteurs;Biologie Aujourd’hui;2021

2. Convenient access to L-3,4,5-trioxygenated phenylalanine compounds from L-tyrosine;Tetrahedron;2020-06

3. Exploration of novel macrocyclic dipeptide N-benzyl amides as proteasome inhibitors;European Journal of Medicinal Chemistry;2019-02

4. Structure-based design of human immuno- and constitutive proteasomes inhibitors;European Journal of Medicinal Chemistry;2018-02

5. Design, synthesis and biological evaluation of novel non-covalent piperidine-containing peptidyl proteasome inhibitors;Bioorganic & Medicinal Chemistry;2016-12